EVGN
Evogene Ltd.
Latest Form 4:Purchase$677byTarcic Gabi (Chief Development Officer) · filed Aug 26, 2026
Evogene Ltd. (EVGN) has 3 SEC Form 4 filings (3 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Aug 26, 2026.
Insiders have net bought $693K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Ofer Haviv
- Employees:52
- HQ:Rehovot, HM, IL
- IPO:2010-10-15
Insider Buying
$693K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$4.8M
Price slightly stale
| Source | ||||||
|---|---|---|---|---|---|---|
Tarcic GabiFirst filing | Chief Development Officer | Purchase | 1,129 | $677 | Aug 26 | SEC ↗ |
| Director | Purchase | 460,000 | $292K | Aug 13 | SEC ↗ | |
RECANATI LEONFirst filing | Director | Purchase | 800,000 | $400K | Aug 5 | SEC ↗ |
Related companies
Evogene Ltd. is in the Manufacturing sector.